Zobrazeno 1 - 10
of 29
pro vyhledávání: '"P. Hugo M. Van Der Kuy"'
Autor:
Ngoc H. Tan, Melvin Lafeber, Roos S. G. Sablerolles, Isabelle Veerman Roders, Anna van de Hoef, Karenin van Grafhorst, Leo G. Visser, Douwe F. Postma, Abraham Goorhuis, Wim J. R. Rietdijk, P. Hugo M. van der Kuy
Publikováno v:
Trials, Vol 25, Iss 1, Pp 1-8 (2024)
Abstract Background Electronic informed consent (eConsent) usage has expanded in recent years in Europe, especially during the pandemic. Slow recruitment rate and limitations in participant outreach are the challenges often faced in clinical research
Externí odkaz:
https://doaj.org/article/f9ff3defdbea4d9dbc89791a2492116c
Autor:
Wim J. R. Rietdijk, Madzy Maljaars-Hendrikse, Monique van Dijk, Romana F. Malik, Ngoc Tan, P. Hugo M. van der Kuy
Publikováno v:
Frontiers in Medicine, Vol 11 (2024)
BackgroundAn open organizational culture in the workplace represents an environment where information, ideas, and feedback are freely exchanged among all members, regardless of position or rank. Currently, there are no valid survey instruments to mea
Externí odkaz:
https://doaj.org/article/b284bbb4f1124fe8bc4c1e4dd27eda1e
Autor:
Luca M. Zaeck, Ngoc H. Tan, Wim J. R. Rietdijk, Daryl Geers, Roos S. G. Sablerolles, Susanne Bogers, Laura L. A. van Dijk, Lennert Gommers, Leanne P. M. van Leeuwen, Sharona Rugebregt, Abraham Goorhuis, Douwe F. Postma, Leo G. Visser, Virgil A. S. H. Dalm, Melvin Lafeber, Neeltje A. Kootstra, Anke L. W. Huckriede, Bart L. Haagmans, Debbie van Baarle, Marion P. G. Koopmans, SWITCH-ON Research Group, P. Hugo M. van der Kuy, Corine H. GeurtsvanKessel, Rory D. de Vries
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-12 (2024)
Abstract Waning antibody responses after COVID-19 vaccination combined with the emergence of the SARS-CoV-2 Omicron lineage led to reduced vaccine effectiveness. As a countermeasure, bivalent mRNA-based booster vaccines encoding the ancestral spike p
Externí odkaz:
https://doaj.org/article/7b4e0251847c419a88ac331e321a07cb
Autor:
Aimée E. M. J. H. Linkens, Dennis Kurstjens, N. Anne Zwietering, Vanja Milosevic, Kim P. G. M. Hurkens, Noémi van Nie, Bob P. A. van de Loo, P. Hugo M. van der Kuy, Bart Spaetgens
Publikováno v:
Drugs - Real World Outcomes, Vol 10, Iss 3, Pp 363-370 (2023)
Abstract Background Inappropriate prescribing is associated with negative patient outcomes. In hospitalized patients, the use of Clinical Decision Support Systems (CDSSs) may reduce inappropriate prescribing and thereby improve patient-related outcom
Externí odkaz:
https://doaj.org/article/8fbe27476a954e10bbd949f42f314ce5
Autor:
Daryl Geers, Roos S.G. Sablerolles, Debbie van Baarle, Neeltje A. Kootstra, Wim J.R. Rietdijk, Katharina S. Schmitz, Lennert Gommers, Susanne Bogers, Nella J. Nieuwkoop, Laura L.A. van Dijk, Eva van Haren, Melvin Lafeber, Virgil A.S.H. Dalm, Abraham Goorhuis, Douwe F. Postma, Leo G. Visser, Anke L.W. Huckriede, Alessandro Sette, Alba Grifoni, Rik L. de Swart, Marion P.G. Koopmans, P. Hugo M. van der Kuy, Corine H. GeurtsvanKessel, Rory D. de Vries
Publikováno v:
iScience, Vol 26, Iss 1, Pp 105753- (2023)
Summary: The emergence of novel SARS-CoV-2 variants led to the recommendation of booster vaccinations after Ad26.COV2.S priming. It was previously shown that heterologous booster vaccination induces high antibody levels, but how heterologous boosters
Externí odkaz:
https://doaj.org/article/7025f88ac3c142ad82c99ff25f52018b
Autor:
Roos S. G. Sablerolles, Abraham Goorhuis, Corine H. GeurtsvanKessel, Rory D. de Vries, Anke L. W. Huckriede, Marion P. G. Koopmans, Melvin Lafeber, Douwe F. Postma, Debbie van Baarle, Leo G. Visser, Virgil A. S. H. Dalm, Neeltje A. Kootstra, Wim J. R. Rietdijk, P. Hugo M. van der Kuy
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Externí odkaz:
https://doaj.org/article/21c54a720c2448ea8a74e527222a33ae
Autor:
Birgit H Rasmussen, Vilma Tripodoro, Gabriel Goldraij, John Ellershaw, Stephen Mason, Agnes van der Heide, Carin C D van der Rijt, Lia van Zuylen, Judit Simon, Michael Berger, Raymond Voltz, Melanie Joshi, Claudia Fischer, Katrin Ruth Sigurdardottir, Julia Strupp, Berivan Yildiz, Valgerdur Sigurdardottir, Hugo M van der Kuy, Steffen Eychmüller, Simon Allan, Rosemary Hughes, Tamsin Mcglinchey, Ida J Korfage, Carl Johan Fürst, Anne Goossensen, Mark Boughey, Dagny Faksvåg Haugen, Urska Lunder, Pilar Barnestein-Fonseca, Misa Bakan, Andri Christen, Gustavo G De Simone, Martina Egloff, Eline E C M Elsten, Eric C T Geijteman, Svandis Iris Halfdanardottir, Christel Hedman, Tanja Hoppe, Grethe Skorpen Iversen, Hana Kodba-Ceh, Nora Lüthi, Maria Luisa Martín-Roselló, Silvi Montilla, Inmaculada Ruiz-Torreras, Maria E C Schelin, Ruthmarijke Smeding, Kjersti Solvåg, Verónica I Veloso, Eva Vibora-Martin, Sofia C Zambrano
Publikováno v:
BMJ Open, Vol 12, Iss 8 (2022)
Introduction Adequately addressing the needs of patients at the end of life and their relatives is pivotal in preventing unnecessary suffering and optimising their quality of life. The purpose of the iLIVE study is to contribute to high-quality perso
Externí odkaz:
https://doaj.org/article/5f96b85320af4d128e30f2b2997c5a6b
Autor:
Agnes E M Looijen, Reinier C A van Linschoten, Jan-Dietert Brugma, Dirk Jan Hijnen, Pascal H P de Jong, P Hugo M van der Kuy, Jan A M van Laar, C Janneke van der Woude, Annelieke Pasma
Publikováno v:
JMIR Research Protocols, 12:e43230. JMIR Publications Inc.
Background Despite enormous clinical improvements, due to better management strategies and the availability of biologicals, immune-mediated inflammatory diseases (IMIDs) still have a significant impact on patients’ lives. To further reduce disease
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::107b3896e52325be5de1137877245ec7
https://doi.org/10.2196/43230
https://doi.org/10.2196/43230
Autor:
Romy van der Groef, Pascal HP de Jong, Dirk Jan Hijnen, Christien J van der Woude, Jan AM van Laar, P Hugo M van der Kuy, Jan-Dietert Brugma, Annelieke Pasma
Publikováno v:
Patient Preference and Adherence, 17, 167-174. Dove Medical Press Ltd.
Romy van der Groef,1 Pascal HP de Jong,1 Dirk Jan Hijnen,2 Christien J van der Woude,3 Jan AM van Laar,4 P Hugo M van der Kuy,5 Jan-Dietert Brugma,6 Annelieke Pasma1 1Department of Rheumatology, Erasmus University Medical Center, Rotterdam, the Nethe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0ab86880bceda22fc16b3ca360a2dd5
https://pure.eur.nl/en/publications/7c17018c-d8e9-44d2-8324-38374f7760ab
https://pure.eur.nl/en/publications/7c17018c-d8e9-44d2-8324-38374f7760ab
Autor:
Agnes E M Looijen, Reinier C A van Linschoten, Jan-Dietert Brugma, Dirk Jan Hijnen, Pascal H P de Jong, P Hugo M van der Kuy, Jan A M van Laar, C Janneke van der Woude, Annelieke Pasma
BACKGROUND Despite enormous clinical improvements, due to better management strategies and the availability of biologicals, immune-mediated inflammatory diseases (IMIDs) still have a significant impact on patients’ lives. To further reduce disease
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6653190d29992b13925e3e48cbb4550c
https://doi.org/10.2196/preprints.43230
https://doi.org/10.2196/preprints.43230